IL-1β is a prominent pro-inflammatory mediator [50] that is also involved in the pathogenesis of type 2 diabetes (T2D) through activation of the NLRP3 inflammasome [51]. The gene discussed is IL1B; the disease is type 2 diabetes mellitus.